Mill River, MA, United States of America

Jackson Liscombe

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Modality.ai. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jackson Liscombe: Innovator in Mental Health Technology

Introduction

Jackson Liscombe is an accomplished inventor based in Mill River, MA (US). He has made significant contributions to the field of mental health technology through his innovative patent. His work focuses on utilizing advanced systems to assess and characterize depression in users.

Latest Patents

Liscombe holds a patent for a groundbreaking system titled "Multimodal investigation of speech, text, cognitive and facial video features for characterizing depression with and without medication." This system is designed to remotely determine the potential presence of depression in a user. It includes a virtual agent that administers various tasks to the user, capturing their performance through a camera. The audiovisual data collected is sent to a server, which derives objective metrics applied to a classifying algorithm. If specific metrics meet certain thresholds, the system can identify symptoms of depression in the user. Additionally, it can ascertain whether the user has been taking depression medication.

Career Highlights

Liscombe is currently employed at Modality.ai, where he continues to develop innovative solutions in the mental health space. His work is instrumental in advancing the understanding and treatment of depression through technology.

Collaborations

One of his notable collaborators is Hardik Kothare, with whom he works closely to enhance the capabilities of their projects.

Conclusion

Jackson Liscombe is a pioneering inventor whose work in mental health technology is making a significant impact. His innovative patent demonstrates the potential of technology to improve the assessment and understanding of depression.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…